June 20, 2022 Published in Sunday Mail, by Brad Crouch Excerpts copied below. Read the full article in Sunday Mail at the link at the bottom of the page. A new Covid-19 vaccine designed and manufactured in Adelaide starts human trials this week with potential to become a major export earner – and it doesn’t […]

June 1, 2022 Published on Success Stories austrade.gov.au Australian biologics manufacturer BioCina has plans to further develop its state-of-the-art facility to enable it to make the next generation of mRNA vaccines and other mRNA-based therapies possible. Backed by Australian Government financial support, BioCina is partnering with the University of Adelaide and US-based Cytiva to speed […]

Published in Cosmos Magazine By Ellen Phiddian Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. BioCina’s pharmaceutical manufacturing plant, in Adelaide, is Australia’s only internationally certified microbial fermentation operation – and a lesson in keeping it clean. So how do they do it? Cosmos […]

(SAN DIEGO and ADELAIDE January 26,2022) BioCina, a leading contract development and manufacturing organization (CDMO) announces the appointment of Rick Hancock, Chairman of the Board. Hancock, with over 35 years of experience in life sciences, has held various board, executive and operational positions, developing expertise in cGMP manufacturing including plasmids, regulatory affairs, R & D, and operational […]

(SAN DIEGO and ADELAIDE, November 30, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the official opening of its new biologics manufacturing facility in Adelaide, Australia. The official opening for the research, development and manufacturing biologic plant in Adelaide […]